OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 800-807
Open Access | Times Cited: 12
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 800-807
Open Access | Times Cited: 12
Showing 12 citing articles:
Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE
S Liu, Nan Zhang, Xu Ji, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
S Liu, Nan Zhang, Xu Ji, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Immunotherapy and Cancer: The Multi-Omics Perspective
Clelia Donisi, Andrea Pretta, Valeria Pusceddu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3563-3563
Open Access | Times Cited: 7
Clelia Donisi, Andrea Pretta, Valeria Pusceddu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3563-3563
Open Access | Times Cited: 7
Regulation of PD-L1 glycosylation and advances in cancer immunotherapy
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Letters (2025), pp. 217498-217498
Closed Access
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Letters (2025), pp. 217498-217498
Closed Access
Chimeric Peptide Functionalized Immunostimulant to Orchestrate Photodynamic Immunotherapeutic Effect by PD-L1 Deglycosylation and CD47 Inhibition
Yi Cen, Xin-Xuan Li, Min Wang, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Yi Cen, Xin-Xuan Li, Min Wang, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Integrative In Silico Analysis to Identify Functional and Structural Impacts of nsSNPs on Programmed Cell Death Protein 1 (PD-1) Protein and UTRs: Potential Biomarkers for Cancer Susceptibility
Hakeemah Al-Nakhle, Retaj Al-Shahrani, Jawanah Al-Ahmadi, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 307-307
Open Access
Hakeemah Al-Nakhle, Retaj Al-Shahrani, Jawanah Al-Ahmadi, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 307-307
Open Access
Uncovering global research frontiers in deubiquitinating enzymes and immunotherapy: A bibliometric study
Xia Chen, Yang Qin, Jinfeng Gan, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Xia Chen, Yang Qin, Jinfeng Gan, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Targeting PD-1 post-translational modifications for improving cancer immunotherapy
Jie Shi, Chuan He, Li Chen, et al.
Cell Insight (2025), pp. 100248-100248
Open Access
Jie Shi, Chuan He, Li Chen, et al.
Cell Insight (2025), pp. 100248-100248
Open Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity
Yun Huang, Wen-Qing Zhong, Xiaoyu Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Yun Huang, Wen-Qing Zhong, Xiaoyu Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Regulation of HNRNP family by post-translational modifications in cancer
B Li, Mingxin Wen, Fei Gao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
B Li, Mingxin Wen, Fei Gao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9276-9276
Open Access
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9276-9276
Open Access
